Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Smilebiotek Zhuhai Limited is currently navigating the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The company has 2 pending office actions, which are distributed across 2 distinct examiners. This distribution suggests that the portfolio is facing independent scrutiny from different individuals at the USPTO, rather than being concentrated under a single reviewing officer. Such a spread requires a prosecution strategy that accounts for multiple distinct examination styles and potential variations in procedural requirements.
The technical breadth of these filings is further evidenced by the involvement of 2 distinct art units. This indicates that the company's intellectual property spans multiple specialized classifications within its primary technology area, necessitating a broad understanding of different examination standards. SHIAO, YIH-HORNG is noted as the busiest examiner for the portfolio, currently managing 1 busiest examiner pending action. For patent practitioners, this spread across 2 distinct art units and 2 distinct examiners requires a coordinated effort to ensure that arguments remain consistent across the different technical groups involved in the review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.5% | +75.9% |
| SINGH, SATYENDRA K | 1 | 61.5% | +67.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656010 | ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS | SHIAO, YIH-HORNG | 28d |
| 18689812 | METHOD FOR BUILDING EYE DISEASE MODEL AND APPLICATION THEREOF | SINGH, SATYENDRA K | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18656010 | ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS | SHIAO, YIH-HORNG | 1691 | §102§103§112DPOther | Final Rejection | 28d | Pending | May 06, 2024 |
| 18689812 | METHOD FOR BUILDING EYE DISEASE MODEL AND APPLICATION THEREOF | SINGH, SATYENDRA K | 1657 | §103 | Non-Final OA | — | Pending | Mar 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial